首页> 外文期刊>Chemistry central journal >Synthesis, molecular modelling and biological significance of N -(4-(4-bromophenyl) thiazol-2-yl)-2-chloroacetamide derivatives as prospective antimicrobial and antiproliferative agents
【24h】

Synthesis, molecular modelling and biological significance of N -(4-(4-bromophenyl) thiazol-2-yl)-2-chloroacetamide derivatives as prospective antimicrobial and antiproliferative agents

机译:N-(4-(4-溴苯基)噻唑-2-基)-2-氯乙酰胺衍生物作为预期的抗微生物和抗增殖剂的合成,分子模型和生物学意义

获取原文
获取外文期刊封面目录资料

摘要

To combat the antimicrobial and anticancer drug resistance by pathogens and cancerous cells, eforts has been madeto study the pharmacological activities of newly synthesized N-(4-(4-bromophenyl)thiazol-2-yl)-2-chloroacetamidederivatives. The molecular structures of the synthesized derivatives were confrmed by their physicochemical properties and spectroanalytical data (NMR, IR and elemental). The synthesized compounds were evaluated for their in vitroantimicrobial activity against bacterial (Gram positive and Gram negative) and fungal species using turbidimetricmethod and anticancer activity against oestrogen receptor positive human breast adenocarcinoma cancer cell line(MCF7) by Sulforhodamine B (SRB) assay. Molecular docking studies were carried out to study the binding mode ofactive compounds with receptor using Schrodinger v11.5. The antimicrobial activity results revealed that compoundsd1, d2 and d3 have promising antimicrobial activity. Anticancer screening results indicated that compounds d6and d7 were found to be the most active ones against breast cancer cell line. Furthermore, the molecular dockingstudy demonstrated that compounds d1, d2, d3, d6 and d7 displayed good docking score within binding pocketof the selected PDB ID (1JIJ, 4WMZ and 3ERT) and has the potential to be used as lead compounds for rational drugdesigning.
机译:为了对抗病原体和癌细胞的抗微生物和抗癌药耐药性,已努力研究新合成的N-(4-(4-溴苯基)噻唑-2-基)-2-氯乙酰胺衍生物的药理活性。合成衍生物的分子结构受到其理化性质和光谱分析数据(NMR,IR和元素)的限制。通过比浊法评估合成的化合物对细菌(革兰氏阳性和革兰氏阴性)和真菌物种的体外抗菌活性,以及​​对磺胺多巴酚B(SRB)测定对雌激素受体阳性的人乳腺癌细胞株(MCF7)的抗癌活性。使用Schrodinger v11.5进行了分子对接研究,以研究活性化合物与受体的结合方式。抗菌活性结果表明,化合物d1,d2和d3具有良好的抗菌活性。抗癌筛选结果表明,化合物d6和d7被发现对乳腺癌细胞活性最高。此外,分子对接研究表明,化合物d1,d2,d3,d6和d7在所选PDB ID(1JIJ,4WMZ和3ERT)的结合口袋中显示出良好的对接分数,并有可能被用作合理药物设计的先导化合物。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号